Sanofi Pasteur finally caved in to government pressure and agreed to refund the cost of the unused vials of its ineffective anti-dengue vaccine Dengvaxia.
The public would normally welcome such statement as a sign the offending party was taking responsibility for its faults. Such is not the case with the French pharmaceutical giant.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.